Evidence map›Paper›PMID 36276164›Full record

ArticleFrontiers in oncology2022

Laparoscopic treatment for an intrapancreatic accessory spleen: A case report.

Yihan Zhang, Guodong Shi, Lingdong Meng, Jing Wu, Qingqiao Hu, Dong Xv, Kai Zhang, Zipeng Lu, Junlii Wu, Kuirong Jiang

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Yihan ZhangPancreas Center, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Guodong ShiPancreas Center, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Lingdong MengPancreas Center, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Jing WuDepartment of Pathology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Qingqiao HuDepartment of Nuclear Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Dong XvPancreas Center, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Kai ZhangPancreas Center, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Zipeng LuPancreas Center, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Junlii WuPancreas Center, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Kuirong JiangPancreas Center, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Jiangsu Province Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant pancreatic tumors have early metastasis, aggressive behavior and poor prognosis. Surgeons often need to judge whether a patient needs prompt surgery when a pancreatic lesion is found. The accessory spleen is a congenital developmental malformation rather than a tumor and does not require surgical resection. Here, we report a 47-year-old man who underwent routine gastroscopic examination, and a submucosal eminence of the duodenal bulb was detected. The patient was asymptomatic and laboratory tests were unremarkable. Duodenal neuroendocrine neoplasm (G2) was considered following endoscopic submucosal dissection (ESD). Further examination showed a lesion in the tail of the pancreas and multiple accessory spleens. The lesion in the tail of the pancreas was Ga-68 positive and was highly considered a pancreatic neuroendocrine tumor (pNET). Based on this clinical evidence, laparoscopic spleen-preserving distal pancreatectomy (Kimura) was performed. However, the results of the postoperative pathological diagnosis indicated an intrapancreatic accessory spleen (IPAS). Given the findings of this case, we should explore more accurate diagnostic methods for IPAS to avoid unnecessary surgery.

Indexed as

imaging diagnosisintrapancreatic accessory spleenpancreatic neuroendocrine tumorpathological diagnosissurgery

Identifiers

PMID36276164
PMCPMC9581263
OpenAlexW4301430617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.